cGMP Readiness of Saturn™ mAb Facilities
2018-01-18
FUJIFILM Corporation (President: Kenji Sukeno) today announced the on-time completion of Qualification activities, enabling commencement of cGMP operations for its Saturn™ mAb manufacturing facilities at FUJIFILM Diosynth Biotechnologies (“FDB”), a world leading cGMP Contract Development and Manufacturing Organization in College Station, Texas. In addition, FDB also announced the expansion of its Apollo™ cell line development capacity at its Billingham, U.K. site.